[Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
Glucocorticoids were widely used for the treatment of various disorders. Therefore, the management of glucocorticoid-induced osteoporosis (GIOP) is referred to doctors who take care of underlying diseases. Since glucocorticoid-induced bone loss is most rapid during the initial 3-6 months, primary prevention of bone loss is especially important.The Japanese Society of Bone and Mineral Metabolism have devised a guideline for the management of GCOP and bisphosphonates play a central role for the primary and secondary prevention of GIOP. Human PTH (1-34) , teriparatide is possible another beneficial drug in addition to bisphosphonates.